SMid & Large Cap Biotech Analysts Romero, Fye and Rama, along with Dr. David King-Stephens from Yale School of Medicine, discuss their perspectives on the focal epilepsy landscape on an Analyst/Industry conference call to be held on April 25 at 2 pm. Webcast Link
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on XENE:
- JPMorgan SMid cap biotech analyst to hold analyst/industry conference call
- 3 Best Stocks to Buy Now, 4/25/2023, According to Top Analysts
- Xenon Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald
- JPMorgan reiterates Xenon as top pick, ups price target
- Xenon Pharmaceuticals announces upcoming presentations at 2023 AAN
